Showing results (21-30 of 1,550) with videos related to

Sort By:
Pageof 155
Therapeutic Advances in Gastroenterology|November 25, 2024
Clinical course for pancreatic necrosis and pancreatic pseudocysts due to severe acute or chronic pancreatitisStefano Fusco, Greta M Hanke, Karsten Büringer, et al.
Therapeutic Advances in Gastroenterology|December 24, 2024
Early intervention with Ustekinumab is associated with higher rates of clinical and endoscopic remission in patients with Crohn's diseaseTong Tu, Mengqi Chen, Manying Li, et al.
Therapeutic Advances in Gastroenterology|December 12, 2024
Endoscopic innovations in diagnosis and management of pancreatic cancer: a narrative review and future directionsPrateek Suresh Harne, Vaishali Harne, Curtis Wray, et al.
Therapeutic Advances in Gastroenterology|December 24, 2024
Mediation role of body mass index in the relationship between food-specific serum immunoglobulin G reactivity and colorectal adenomas in a Chinese population: a cross-sectional studyGuanchao Sun, Xiaona Ma, Shiping Xu, et al.
Therapeutic Advances in Gastroenterology|November 18, 2024
Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniquesDavid Hudson, Tamoor Afzaal, Hasan Bualbanat, et al.
Therapeutic Advances in Gastroenterology|February 24, 2025
Itopride in functional dyspepsia: open-label, 1-year treatment follow-up of two multicenter, randomized, double-blind, placebo-controlled trialsBert Broeders, Jan Tack, Nicholas J Talley
Therapeutic Advances in Gastroenterology|November 4, 2024
Mirtazapine for gastrointestinal and neuropsychological symptoms in older adults with irritable bowel syndromeAyesha Khan, Raakhi Menon, Brooke Corning, et al.
Therapeutic Advances in Gastroenterology|November 17, 2025
JAK inhibitors in the management of extra-intestinal manifestations in inflammatory bowel diseaseFotios S Fousekis, André Jefremow, Konstantinos H Katsanos, et al.
Therapeutic Advances in Gastroenterology|November 3, 2025
Microbiota-targeted strategies in IBD: therapeutic promise of 2'-fucosyllactose and beyondNicholas Fanous, Nicholas J Talley, Thanaboon Chaemsupaphan, et al.
Therapeutic Advances in Gastroenterology|October 13, 2025
Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysisMarc Ferrante, Laurent Peyrin-Biroulet, Perttu Arkkila, et al.
Pageof 155